Assertio Holdings, Inc.
- ASRT
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Specialty Pharma (Neurology/Pain)
$23.50
Quote Jun 15, 2026, 08:00 PM UTC
+0.26%over the last month
Max drawdown −0.2%From 1-month high 0.0%3 months +21.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$151.9M
Quote Jun 15
Next earnings
—
Data unavailable
Analyst target
$22.65
−3.6% from here
Floor
$23.47
0.1% below price
Where the price sits
18 analysts
Analyst range, low to high
$21.80$23.50
- Price $23.50
- Consensus $22.65
The price is just above its floor. Analysts' average target sits about 4% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ASRTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q1 2026 revenue $15.8M
- Product$8.9M56.5%
- INDOCIN Products$3.4M21.9%
- SPRIX Nasal Spray$1.4M8.7%
- Product, Other$1.0M6.4%
- Product and Service, Other$600,0003.8%
- Royalty$435,0002.8%
Industry
Drug Manufacturers - Specialty & Generic
Employees
58